Interstitial Lung Disease: The Consequences of Misdiagnoses

Enfermedad pulmonar intersticial

By América Torres Interstitial lung diseases (ILDs) encompass many unrelated conditions with both known and unknown etiologies, which often present diagnostic and therapeutic difficulties for treating physicians. Many believe that early specific diagnosis and immediate management are of no value, as the prognosis and treatment response are universally poor. Due to this belief, many patients […]

EVALI: The critical role of vaping in lung injury cases

By América Torres Photo: Prostooleh/Freepik Vaping as the Cause of EVALI (E-cigarette or Vaping Product Use–Associated Lung Injury), a pulmonary disease that can be severe and potentially life-threatening. The term was coined at the same time the disease was first recognized in August 2019. It is important to clarify that EVALI is not a clinical […]

Advanced Oscillometry Insights: Managing Asthma and COPD

By América Torres Oscillometry is a non-invasive method for measuring the mechanical properties of the respiratory system, which can enhance our understanding and management of lung diseases such as asthma and COPD. This technique offers special advantages in situations where spirometry and other lung function tests are not suitable for patients, such as infants, people […]

Press Release: SCHILLER Americas Earns Technology Breakthrough Designation with Premier, Inc.

SCHILLER Americas Photo: SCHILLER CONTACT: Michael Schulz, michael.schulz@schilleramericas.com, +1 (417) 527 – 0396 FOR IMMEDIATE RELEASE SCHILLER Americas awarded Pulmonary Function and Metabolic Analyzers agreement and Technology Breakthrough Designation with Premier, Inc.  Doral, Florida – 5/28/2024 – SCHILLER Americas has been awarded a national group purchasing agreement and Technology Breakthrough Designation for Pulmonary Function and Metabolic […]

2023 American College of Rheumatology  Guideline for the Screening andMonitoring of Interstitial Lung Disease in Patients with Systemic AutoimmuneRheumatic Disease

By América Torres peoplecreations/Freepik With the aim of providing you with information that may be useful in your medical practice, the Guide have summarized the main recommendations of the 2023 American College of Rheumatology Guideline for the Detection and Monitoring of Interstitial Lung Disease (ILD) in individuals with systemic autoimmune disease. Rheumatic disease. This clinical […]

Pulmonary diseases: when the profession is a risk

By América Torres Many professions carry the risk of developing pulmonary diseases. The lungs are organs with an extensive surface area, high vascularity, and a thin barrier between air and blood. This structure makes them a contact site for environmental agents, many of which have local and/or systemic or immunological toxic effects. Exposures to toxic […]

Diagnosis of Asthma: Challenges and Solutions

The diagnosis of asthma is an urgent need for two main reasons. The first is that it is estimated to affect 300 million people worldwide. And the second is that asthma treatment generates high costs for healthcare institutions and patients.1 Although current asthma guidelines use both clinical criteria and spirometry-based criteria to define the severity […]

The crucial role of spirometry to enhance lung health

By América Torres Spirometry is fundamental in the assessment of overall pulmonary function. It allows analyzing the impact on lung function caused by various diseases, evaluating the airways’ response to medical treatment, monitoring the disease’s progression, or the outcome of therapeutic interventions, and determining the prognosis for many pulmonary conditions. In this article, we will […]

Clinical Advances in Pulmonary Health 2023

By América Torres Photo: rawpixel.com/Freepik The constant search for innovative solutions and more effective treatments has led to significant progress in the research of pulmonary diseases, marking a milestone in the understanding and approach to these medical conditions.   In this blog, we highlight some of the milestones reached in pulmonary health research. We mention […]

LFX Software: SCHILLER’s Solution for Pulmonary Function Testing

By América Torres SCHILLER‘s LFX Software is a comprehensive solution for pulmonary function testing that can make a significant difference in the care of patients with respiratory conditions. It is a user-friendly patient management platform that provides healthcare professionals with sophisticated tools to conduct high-quality lung assessments.   At SCHILLER- GANSHORN, we understand the importance […]

CONTACT US

Share your information with us to receive advice from a product specialist. By submitting the form, you will be able to download our Product Catalog to learn about all the solutions we offer.

Select your country or region